tetano
Editor, Senior Moderator
BMC Infect Dis
. 2024 Aug 29;24(1):883.
doi: 10.1186/s12879-024-09767-2. Predictors of the presence of radiological abnormalities 6 months after severe COVID-19 pneumonia
Celia Roig-Martí[SUP] #[/SUP][SUP] 1 [/SUP], Ignacio Pérez-Catalán[SUP] #[/SUP][SUP] 2 [/SUP], María Varea-Villanueva[SUP] 3 [/SUP], Sofía Folgado-Escudero[SUP] 3 [/SUP], Antonio Navarro-Ballester[SUP] 4 [/SUP], María Pilar Fernández-García[SUP] 4 [/SUP], Ana Segura-Fábrega[SUP] 3 [/SUP], Germán Herrero-Rodríguez[SUP] 3 [/SUP], Elena Domínguez-Bajo[SUP] 3 [/SUP], Sergio Fabra-Juana[SUP] 3 [/SUP], María-José Esteve-Gimeno[SUP] 3 [/SUP], María-Lidón Mateu-Campos[SUP] 5 [/SUP], Jorge Usó-Blasco[SUP] #[/SUP][SUP] 3 [/SUP], José-Manuel Ramos-Rincón[SUP] #[/SUP][SUP] 6 7 [/SUP]
Affiliations
Background: SARS-CoV-2 pneumonia can cause significant long-term radiological changes, even resembling pulmonary fibrosis. However, the risk factors for these long-term effects are unknown. This study aims to assess radiological abnormalities and their possible risk factors six months after hospital discharge due to COVID-19 pneumonia.
Material and methods: This cross-sectional study in a tertiary hospital included adults admitted for COVID-19 pneumonia from March 2020 to February 2021, who underwent high-resolution computed tomography (HRCT) scans of the chest six months after hospital discharge. The primary outcome was radiological abnormalities on HRCT, while the main explanatory variables were drawn from the patient's medical history along with the disease course, analytical indicators, and the treatment received during admission.
Results: The 189 included patients had a mean age of 61.5 years; 70.9% were male, and hypertension was the main comorbidity (45%). About two-thirds (67.2%) presented acute respiratory distress syndrome (ARDS). Most (97.9%) received systemic corticosteroid therapy, and 81% presented pathological findings on HRCT, most commonly ground glass (63.5%), followed by bronchial dilatation (36%) and subpleural bands (25.4%). The multivariable analysis showed that age was the main risk factor, associated with most radiological changes. Other factors were the duration of corticosteroid therapy for ground glass (adjusted odds ratio [aOR] 1.020) as well as a longer stay in the intensive care unit (ICU) (aOR 1.290) and high levels of IL-6 for bronchial dilation (aOR 1.002).
Conclusion: Radiological involvement of the lungs six months after COVID-19 pneumonia is frequent, especially ground glass. Elderly patients with prolonged ICU admission and a significant inflammatory response measured by IL-6 are more likely to present worse radiological evolution and are candidates for radiological follow-up after COVID-19 pneumonia.
Keywords: COVID-19; Pneumonia; Pulmonary Fibrosis; SARS-CoV-2; Tomography.
. 2024 Aug 29;24(1):883.
doi: 10.1186/s12879-024-09767-2. Predictors of the presence of radiological abnormalities 6 months after severe COVID-19 pneumonia
Celia Roig-Martí[SUP] #[/SUP][SUP] 1 [/SUP], Ignacio Pérez-Catalán[SUP] #[/SUP][SUP] 2 [/SUP], María Varea-Villanueva[SUP] 3 [/SUP], Sofía Folgado-Escudero[SUP] 3 [/SUP], Antonio Navarro-Ballester[SUP] 4 [/SUP], María Pilar Fernández-García[SUP] 4 [/SUP], Ana Segura-Fábrega[SUP] 3 [/SUP], Germán Herrero-Rodríguez[SUP] 3 [/SUP], Elena Domínguez-Bajo[SUP] 3 [/SUP], Sergio Fabra-Juana[SUP] 3 [/SUP], María-José Esteve-Gimeno[SUP] 3 [/SUP], María-Lidón Mateu-Campos[SUP] 5 [/SUP], Jorge Usó-Blasco[SUP] #[/SUP][SUP] 3 [/SUP], José-Manuel Ramos-Rincón[SUP] #[/SUP][SUP] 6 7 [/SUP]
Affiliations
- PMID: 39210255
- PMCID: PMC11360858
- DOI: 10.1186/s12879-024-09767-2
Background: SARS-CoV-2 pneumonia can cause significant long-term radiological changes, even resembling pulmonary fibrosis. However, the risk factors for these long-term effects are unknown. This study aims to assess radiological abnormalities and their possible risk factors six months after hospital discharge due to COVID-19 pneumonia.
Material and methods: This cross-sectional study in a tertiary hospital included adults admitted for COVID-19 pneumonia from March 2020 to February 2021, who underwent high-resolution computed tomography (HRCT) scans of the chest six months after hospital discharge. The primary outcome was radiological abnormalities on HRCT, while the main explanatory variables were drawn from the patient's medical history along with the disease course, analytical indicators, and the treatment received during admission.
Results: The 189 included patients had a mean age of 61.5 years; 70.9% were male, and hypertension was the main comorbidity (45%). About two-thirds (67.2%) presented acute respiratory distress syndrome (ARDS). Most (97.9%) received systemic corticosteroid therapy, and 81% presented pathological findings on HRCT, most commonly ground glass (63.5%), followed by bronchial dilatation (36%) and subpleural bands (25.4%). The multivariable analysis showed that age was the main risk factor, associated with most radiological changes. Other factors were the duration of corticosteroid therapy for ground glass (adjusted odds ratio [aOR] 1.020) as well as a longer stay in the intensive care unit (ICU) (aOR 1.290) and high levels of IL-6 for bronchial dilation (aOR 1.002).
Conclusion: Radiological involvement of the lungs six months after COVID-19 pneumonia is frequent, especially ground glass. Elderly patients with prolonged ICU admission and a significant inflammatory response measured by IL-6 are more likely to present worse radiological evolution and are candidates for radiological follow-up after COVID-19 pneumonia.
Keywords: COVID-19; Pneumonia; Pulmonary Fibrosis; SARS-CoV-2; Tomography.